Guilherme Violante Cunha

Guilherme Violante Cunha

Auto-generated profile, based on publicly available information

Guilherme Violante Cunha

Internal Medicine, Unidade Local de Saúde da Região de Aveiro, Aveiro, Portugal

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 March 2016 in Journal of NeuroEngineering and Rehabilitation
Verified
Journal Article
Open access
PDF file
Catarina GodinhoCatarina Godinho
Catarina Godinho
JDJosefa Domingos
Josefa Domingos
GCGuilherme Cunha
Guilherme Cunha
ASAna T. Santos
Ana T. Santos
RFRicardo M. Fernandes
Ricardo M. Fernandes
Joaquim FerreiraJoaquim Ferreira
Joaquim Ferreira
There is growing interest in having objective assessment of health-related outcomes using technology-based devices that provide unbiased measurements which can be used in clinical practice and scientific research. Many studies have investigated the clinical manifestations of Parkinson’s disease using such devices. However, clinimetric properties and clinical validation vary among the different devices. Given such heterogeneity, we sought to perform a systematic review in order to (i) list, (ii) compare and (iii) classify technological-based devices used to measure motor function in individuals with Parkinson's disease into three groups, namely wearable, non-wearable and hybrid devices. A systematic literature search of the PubMed database resulted in the inclusion of 168 studies. These studies were grouped based on the type of device used. For each device we reviewed availability, use, reliability, validity, and sensitivity to change. The devices were then classified as (i) ‘recommended’, (ii) ‘suggested’ or (iii) ‘listed’ based on the following criteria: (1) used in the assessment of Parkinson’s disease (yes/no), (2) used in published studies by people other than the developers (yes/no), and (3) successful clinimetric testing (yes/no). Seventy-three devices were identified, 22 were wearable, 38 were non-wearable, and 13 were hybrid devices. In accordance with our classification method, 9 devices were ‘recommended’, 34 devices were ‘suggested’, and 30 devices were classified as ‘listed’. Within the wearable devices group, the Mobility Lab sensors from Ambulatory Parkinson’s Disease Monitoring (APDM), Physilog®, StepWatch 3, TriTrac RT3 Triaxial accelerometer, McRoberts DynaPort, and Axivity (AX3) were classified as ‘recommended’. Within the non-wearable devices group, the Nintendo Wii Balance Board and GAITRite® gait analysis system were classified as ‘recommended’. Within the hybrid devices group only the Kinesia® system was classified as ‘recommended’.

23 June 2026 in BMJ Case Reports
Verified
Journal Article
Closed access
JFJoão Ricardo Cordeiro Rei De Campos Faia
João Ricardo Cordeiro Rei De Campos Faia
ASAna Paiva Santos
Ana Paiva Santos
SMSofia Martins
Sofia Martins
GCGuilherme Violante Cunha
Guilherme Violante Cunha
Chronic mesenteric ischaemia (CMI) is a rare but potentially life-threatening condition, often underdiagnosed due to its vague and non-specific symptoms. We describe a patient who presented with progressive unintentional weight loss, anorexia and postprandial abdominal pain. Despite extensive investigations, no clear diagnosis was established until CT angiography revealed severe calcified stenosis of the coeliac trunk and superior mesenteric artery. The stenoses of two mesenteric vessels limited perfusion during periods of high metabolic demand, causing postprandial tissue ischaemia, which manifested as abdominal pain, reduced oral intake and consequent weight loss. A multidisciplinary approach led to the diagnosis of CMI and surgical revascularisation via iliomesenteric bypass was performed, resulting in complete resolution of symptoms and weight recovery. This case highlights the importance of considering CMI in older patients with unexplained weight loss and cardiovascular risk factors. Early recognition and timely intervention are crucial to prevent irreversible complications and ensure favourable outcomes.